Expression of PD-1 on Memory T Lymphocytes Predicts 28-Day Mortality of Patients with Sepsis: A Prospective Observational Study

References

• Singer M, Deutschman CS, Seymour CW., et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):801–810. doi:10.1001/jama.2016.0287
   PubMed Web of Science ®Google Scholar
• Rhee C, Dantes R, Epstein L, et al. Incidence and trends of sepsis in US hospitals using clinical vs claims data, 2009-2014. JAMA. 2017;318(13):1241–1249. doi:10.1001/jama.2017.13836
   PubMed Web of Science ®Google Scholar
• Xie J, Wang H, Kang Y, et al. The epidemiology of sepsis in Chinese ICUs: a national cross-sectional survey. Crit Care Med. 2020;48(3):e209–e218.
   PubMed Web of Science ®Google Scholar
• Rhodes A, Evans LE, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med. 2017;43(3):304–377.
   PubMed Web of Science ®Google Scholar
• Hotchkiss RS, Monneret G, Payen D. Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat Rev Immunol. 2013;13(12):862–874.
   PubMed Web of Science ®Google Scholar
• Delano MJ, Ward PA. The immune system’s role in sepsis progression, resolution, and long-term outcome. Immunol Rev. 2016;274(1):330–353.
   PubMed Web of Science ®Google Scholar
• Donnelly JP, Hohmann SF, Wang HE. Unplanned readmissions after hospitalization for severe sepsis at academic medical center-affiliated hospitals. Crit Care Med. 2015;43(9):1916–1927.
   PubMed Web of Science ®Google Scholar
• Hotchkiss RS, Tinsley KW, Swanson PE, et al. Sepsis-induced apoptosis causes progressive profound depletion of B and CD4+ T lymphocytes in humans. J Immunol. 2001;166(11):6952–6963.
   PubMed Web of Science ®Google Scholar
• Jensen IJ, Sjaastad FV, Griffith TS, et al. Sepsis-induced T cell immunoparalysis: the ins and outs of impaired T cell immunity. J Immunol. 2018;200(5):1543–1553.
   PubMed Web of Science ®Google Scholar
• Serbanescu MA, Ramonell KM, Hadley A, et al. Attrition of memory CD8 T cells during sepsis requires LFA-1. J Leukoc Biol. 2016;100(5):1167–1180. doi:10.1189/jlb.4A1215-563RR
   PubMed Web of Science ®Google Scholar
• Condotta SA, Rai D, James BR, et al. Sustained and incomplete recovery of naive CD8 + T cell precursors after sepsis contributes to impaired CD8 + T cell responses to infection. J Immunol. 2013;190(5):1991–2000. doi:10.4049/jimmunol.1202379
   PubMed Web of Science ®Google Scholar
• Condotta SA, Khan SH, Rai D, et al. Polymicrobial sepsis increases susceptibility to chronic viral infection and exacerbates CD8 + T cell exhaustion. J Immunol. 2015;195(1):116–125. doi:10.4049/jimmunol.1402473
   PubMed Web of Science ®Google Scholar
• Chen L, Flies DB. Molecular mechanisms of T cell co-stimulation and co-inhibition. Nat Rev Immunol. 2013;13(4):227–242. doi:10.1038/nri3405
   PubMed Web of Science ®Google Scholar
• McKinney EF, Lee JC, Jayne DRW, et al. T-cell exhaustion, co-stimulation and clinical outcome in autoimmunity and infection. Nature. 2015;523(7562):612–616. doi:10.1038/nature14468
   PubMed Web of Science ®Google Scholar
• Parry RV, Chemnitz JM, Frauwirth KA, et al. CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms. Mol Cell Biol. 2005;25(21):9543–9553. doi:10.1128/MCB.25.21.9543-9553.2005
   PubMed Web of Science ®Google Scholar
• Shindo Y, Unsinger J, Burnham C, et al. Interleukin-7 and anti–programmed cell death 1 antibody have differing effects to reverse sepsis-induced immunosuppression. Shock. 2015;43(4):334–343. doi:10.1097/SHK.0000000000000317
   PubMed Web of Science ®Google Scholar
• Morrow KN, Liang Z, Xue M, et al. The IL-27 receptor regulates TIGIT on memory CD4+ T cells during sepsis. iScience. 2021;24(2):102093. doi:10.1016/j.isci.2021.102093
   PubMed Web of Science ®Google Scholar
• Niu B, Zhou F, Su Y, et al. Different Expression Characteristics of LAG3 and PD-1 in Sepsis and Their Synergistic Effect on T cell Exhaustion: A New Strategy for Immune Checkpoint Blokade. Front Immunol. 2019;10:1888. doi:10.3389/fimmu.2019.01888
   Google Scholar
• Hotchkiss RS, Colston E, Yende S, et al. Immune checkpoint inhibition in sepsis: a Phase 1b randomized study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of nivolumab. Intensive Care Medicine. 2019;45(10):1360–1371. doi:10.1007/s00134-019-05704-z
   PubMed Web of Science ®Google Scholar
• Ramonell KM, Zhang W, Hadley A, et al. CXCR4 blockade decreases CD4+ T cell exhaustion and improves survival in a murine model of polymicrobial sepsis. PLoS One. 2017;12(12):e188882. doi:10.1371/journal.pone.0188882
   PubMed Web of Science ®Google Scholar
• van der Poll T, van de Veerdonk FL, Scicluna BP, et al. The immunopathology of sepsis and potential therapeutic targets. Nat Rev Immunol. 2017;17(7):407–420.
   PubMed Web of Science ®Google Scholar
• Xie J, Crepeau RL, Chen CW, et al. Sepsis erodes CD8(+) memory T cell-protective immunity against an EBV homolog in a 2B4-dependent manner. J Leukoc Biol. 2019;105(3):565–575.
   PubMed Web of Science ®Google Scholar
• Boomer JS, Shuherk-Shaffer J, Hotchkiss RS, et al. A prospective analysis of lymphocyte phenotype and function over the course of acute sepsis. Crit Care. 2012;16(3):R112.
   PubMed Web of Science ®Google Scholar
• Xie J, Chen C, Sun Y, et al. Increased attrition of memory T cells during sepsis requires 2B4. JCI Insight. 2019;4(9):548.
   Web of Science ®Google Scholar
• Bu Y, Wang H, Ma X, et al. Untargeted metabolomic profiling of the correlation between prognosis differences and PD-1 expression in sepsis: a preliminary study. Front Immunol. 2021;12:594270.
   PubMed Web of Science ®Google Scholar
• Thampy LK, Remy KE, Walton AH, et al. Restoration of T cell function in multi-drug resistant bacterial sepsis after interleukin-7, anti-PD-L1, and OX-40 administration. PLoS One. 2018;13(6):e199497.
   PubMed Web of Science ®Google Scholar
• Hotchkiss RS, Colston E, Yende S, et al. Immune checkpoint inhibition in sepsis: a phase 1b randomized, placebo-controlled, single ascending dose study of antiprogrammed cell death-ligand 1 antibody (BMS-936559). Crit Care Med. 2019;47(5):632–642.
   PubMed Web of Science ®Google Scholar
• Brahmamdam P, Inoue S, Unsinger J, et al. Delayed administration of anti-PD-1 antibody reverses immune dysfunction and improves survival during sepsis. J Leukoc Biol. 2010;88(2):233–240.
   PubMed Web of Science ®Google Scholar
• Freeman BE, Hammarlund E, Raue HP, et al. Regulation of innate CD8+ T-cell activation mediated by cytokines. Proc Natl Acad Sci U S A. 2012;109(25):9971–9976.
   PubMed Web of Science ®Google Scholar
• Jensen IJ, Li X, McGonagill PW, et al. Sepsis leads to lasting changes in phenotype and function of memory CD8 T cells. Elife. 2021;1:10.
   Google Scholar